期刊文献+

氟喹诺酮类抗菌药物的不良反应和合理应用 被引量:2

Study on adverse reactions and reasonable application of Fluroquinolones
下载PDF
导出
摘要 目的分析氟喹诺酮类药物在临床应用中不良反应发生的规律,以便采取措施,警惕该类药物不良反应的发生,为临床合理用药提供信息。方法对182例氟喹诺酮类药物不良反应(ADR)报告进行回顾性分析。结果 182例不良反应涉及5种氟喹诺酮类药物,左氧氟沙星、环丙杀星和加替沙星分别为81例(44.50%)、45例(24.72%)和38例(20.87%);不良反应累及人体10个系统,主要表现为皮肤及附件损害69例(37.9%),其次为消化系统和神经系统分别为42例(23.1%)、23例(12.6%)。结论应对氟喹诺酮类药物引起的不良反应加以重视,及时发现并避免不良反应的发生。 Objective To discuss the regular pattern and characteristics of adverse drug reactions(ADRs) caused by Fluroquinolones in order to prevent their occurenee and to provide rational drug use. Methods To analyze retrospectively adverse reactions caused by Fluroquinolones in 182 patients from March 2000 to March 2007 in my hospital. Results Of 5 kinds of Fluroquinolones which caused adverse reactions in 182 eases, Ofloxaein appeared most frequently and Ciprofloxacin secondly and Gatifloxaein thirdly. The major adverse drug reaction was impairment of skin and its accessories (37.9%) and the secondary was impairment of digestive system ( 23. 1% ) and central nervous system( 12. 6% ) respectively. Conclusion Adequate attention should be paid to the adverse reactions caused by Fluroquinolones, in order to discover and prevent their occurence in time.
出处 《中国医学创新》 CAS 2009年第26期15-17,共3页 Medical Innovation of China
关键词 氟喹诺酮类药物 不良反应 合理用药 Fluroquinolones Adverse drug reactions Reasonable application
  • 相关文献

参考文献4

二级参考文献43

  • 1张永利,万献尧.细菌耐药性研究进展[J].中国医师杂志,2004,6(12):1721-1722. 被引量:34
  • 2王浴生,周黎明.喹诺酮类抗菌药毒理学与临床不良反应的几个问题[J].四川生理科学杂志,2004,26(3):123-124. 被引量:17
  • 3Halliwell RF, Davery PG, Lambert JJ. Antagonism of GABA receptor by 4-quinolones[J]. J Antimicrob Chemother, 1993, 31: 457.
  • 4Domagala JM. Structure-activity and structure-side-effect relationships for quinolone antibacterials [J]. J Antimicroh Chemother, 1994, 23: 685.
  • 5William PD, Helton DR. The proconvulsive activity of quinolone antibiotics in an animal model [J]. Toxicol Lett, 1991, 58: 21.
  • 6Schmuck G, Schurmann A, Schluter G, et al. Determination of the excitatory potencyes of different fluoroquinolones in the central nervous system by an in vitro model[J]. Antimicrob Agents Chemother, 1998, 42 :1831.
  • 7Hod S, Shimida J, Sato A, et al. Comparison of the inhibitory effects of new quinolone on gamma-aminobu-tyric acid receptor binding in the presence of anti-inflammatory drugs[J]. Rev Infect Dis, 1989, ( Suppl 5 ) :S1397.
  • 8Robinstein E, Camm J. Cardiotoxicity of fluoroquinolones[J]. J Antimicrob Chemother, 2002,49: 593.
  • 9Hagiwara T, Satch S, Kasai Y, et al. A comparative study of the fluoroquinolone antibacterial agents on the action potential duration in guinea pig ventricular myocardia[J]. Jpn J Pharmacol, 2001,87: 231.
  • 10Anderson ME, Mazur A, Yang T, et al, Potassium current antagonist properties and proarrhythmic consequences of quinolone antibiotic [J]. J Pharmacol Exp Ther, 2001, 296: 806.

共引文献74

同被引文献19

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部